Clinical Trial

Coping Strategies, Loneliness, and Resilience in Patients With Dermatosis

Study acronym: ESDaP3
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The European Society for Dermatology \& Psychiatry (ESDaP) studies the connection between the skin and the mind. Two previous studies of this type were conducted in 13 and 15 European countries, respectively. The first study assessed the psychological impact of skin diseases (anxiety, depression, sleep disorders), and the second analyzed feelings of stigma, stress, and body dysmorphic disorder (an abnormal perception of one's body). In this study, new psychological variables will be examined: coping strategies, loneliness, and resilience. A total of 23 centers will participate in the ESDaP3 study, located in 15 European countries (Austria, France, Germany, Hungary, Italy, North Macedonia, the Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Turkey, and the United Kingdom). The aim of this study is to examine coping strategies, loneliness, and resilience among patients with a skin condition. Coping strategies refer to the various ways a person uses to manage a difficult or stressful situation. Resilience refers to a person's ability to cope with difficult situations, adapt to changes or challenges, and regain a sense of balance despite obstacles. Other factors will be assessed: sleep, anxiety and depression, and quality of life. A questionnaire will be given to your potential partner to assess the impact of the skin condition on their life at this time. At the study's sole French site, Brest University Hospital, 250 patients with a skin condition and 125 people without a skin condition will be enrolled.
Trial Details
NCT Number NCT07640373
Lead Sponsor University Hospital, Brest
Collaborators: University of Graz, Justus-Liebig University Gießen Medical Center, Szeged University, University of Skopje, University of Amsterdam, University of Stavanger, University of Bergen, Wroclaw Medical University, University of Rzeszow, Universidade do Algarve, Universidad de Zaragoza, University of La Laguna, Malmö University, Lund University, Karolinska Institutet, Sisli Hamidiye Etfal Training and Research Hospital, Cardiff University, University Hospital Muenster, Leiden University Medical Center, The Royal London Hospital, UK
Conditions Skin Disease, Skin Disorder, Skin Condition, Inflammatory Skin Conditions, Autoimmune Skin Diseases, Cancerous Skin Conditions, Genetic Skin Conditions
Enrollment 375 participants
Start Date 2026-07
Primary Completion 2029-07 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-10